허밍버드 바이오사이언스(Hummingbird Bioscience) > 포트폴리오 케이엔티인베스트먼트

본문 바로가기

KNT Investment 포트폴리오


허밍버드 바이오사이언스(Hummingbird Bioscience)

본문


투자시기
2020년 12월(딜클로즈시기)

업종
바이오신약개발

회사개요
이중 항체(항암)

홈페이지
hummingbirdbioscience.com

본사
싱가포르

We are a precision biotherapeutics company with proprietary technologies and platforms, developing a broad pipeline of novel, precision therapeutics for the treatment of cancer.
We are focused on developing therapies that can provide deep and durable responses in patients.
At Hummingbird Bioscience, the commitment to rigorous science, teamwork, and intellectual integrity underpins our passion to accelerate the journey of new drugs from concept to clinic.